HEADER TRANSFERASE 23-NOV-21 7QCB TITLE WILLIAMS-BEUREN SYNDROME RELATED METHYLTRANSFERASE WBSCR27 IN COMPLEX TITLE 2 WITH SAH COMPND MOL_ID: 1; COMPND 2 MOLECULE: METHYLTRANSFERASE-LIKE 27; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: WILLIAMS-BEUREN SYNDROME CRITICAL REGION PROTEIN 27, COMPND 5 WILLIAMS-BEUREN SYNDROME CRITICAL REGION PROTEIN 27 ISOFORM ALPHA, COMPND 6 WILLIAMS-BEUREN SYNDROME CRITICAL REGION PROTEIN 27 ISOFORM BETA; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: METTL27, BC002286, WBSCR27; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PET30ATEV; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET30ATEV-WBSCR27 KEYWDS WILLIAMS-BEUREN SYNDROME, SAM-DEPENDENT METHYLTRANSFERASE, ROSSMAN KEYWDS 2 FOLD, CLASS I METHYLTRANSFERASES, TRANSFERASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR V.I.POLSHAKOV,S.S.MARIASINA,C.-F.CHANG,S.V.EFIMOV REVDAT 4 14-JUN-23 7QCB 1 REMARK REVDAT 3 20-JUL-22 7QCB 1 JRNL REVDAT 2 13-JUL-22 7QCB 1 JRNL REVDAT 1 29-DEC-21 7QCB 0 JRNL AUTH S.S.MARIASINA,C.F.CHANG,T.L.NAVALAYEU,A.A.CHUGUNOVA, JRNL AUTH 2 S.V.EFIMOV,V.G.ZGODA,V.A.IVLEV,O.A.DONTSOVA,P.V.SERGIEV, JRNL AUTH 3 V.I.POLSHAKOV JRNL TITL WILLIAMS-BEUREN SYNDROME RELATED METHYLTRANSFERASE WBSCR27: JRNL TITL 2 FROM STRUCTURE TO POSSIBLE FUNCTION. JRNL REF FRONT MOL BIOSCI V. 9 65743 2022 JRNL REFN ESSN 2296-889X JRNL PMID 35782865 JRNL DOI 10.3389/FMOLB.2022.865743 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 2.21 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7QCB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-NOV-21. REMARK 100 THE DEPOSITION ID IS D_1292119285. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 7.00 REMARK 210 IONIC STRENGTH : 100 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.0 MM [U-15N] WBSCR27, 10 MM REMARK 210 SAH, 5 MM DTT, 0.2 % W/V SODIUM REMARK 210 AZIDE, 50 MM SODIUM PHOSPHATE, REMARK 210 50 MM SODIUM CHLORIDE, 95% H2O/5% REMARK 210 D2O; 0.2 MM [U-15N] WBSCR27, 10 REMARK 210 MM SAH, 5 MM DTT, 0.2 % W/V REMARK 210 SODIUM AZIDE, 50 MM SODIUM REMARK 210 PHOSPHATE, 50 MM SODIUM CHLORIDE, REMARK 210 0.225 % V/V PHAGE PF1 STOCK REMARK 210 SOLUTION, 95% H2O/5% D2O; 0.6 MM REMARK 210 [U-95% 13C; U-99% 15N] WBSCR27, REMARK 210 0.6 MM SAH, 5 MM DTT, 0.2 % W/V REMARK 210 SODIUM AZIDE, 50 MM SODIUM REMARK 210 PHOSPHATE, 50 MM SODIUM CHLORIDE, REMARK 210 95% H2O/5% D2O; 0.6 MM [U-95% REMARK 210 13C; U-99% 15N] WBSCR27, 0.6 MM REMARK 210 SAH, 5 MM DTT, 0.2 % W/V SODIUM REMARK 210 AZIDE, 50 MM SODIUM PHOSPHATE, REMARK 210 50 MM SODIUM CHLORIDE, 100% D2O; REMARK 210 0.3 MM [U-95% 15N] WBSCR27, 0.3 REMARK 210 MM [U-95% 13C; U-99% 15N] SAH, 5 REMARK 210 MM DTT, 0.2 % W/V SODIUM AZIDE, REMARK 210 50 MM SODIUM PHOSPHATE, 50 MM REMARK 210 SODIUM CHLORIDE, 100% D2O; 0.3 REMARK 210 MM [U-95% 15N] WBSCR27, 0.3 MM REMARK 210 [U-95% 13C; U-99% 15N] SAH, 5 MM REMARK 210 DTT, 0.2 % W/V SODIUM AZIDE, 50 REMARK 210 MM SODIUM PHOSPHATE, 50 MM REMARK 210 SODIUM CHLORIDE, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCO; 3D REMARK 210 HNCACO; 3D HN(CO)CA; 3D CBCA(CO) REMARK 210 NH; 3D HNCACB; 3D HBHA(CO)NH; 3D REMARK 210 HNHAHB; 3D 1H-15N TOCSY; 3D HCCH- REMARK 210 TOCSY; 3D 1H-13C NOESY; 3D 15N- REMARK 210 1H NOESY; IPAP; 2D 1H-13C HSQC; REMARK 210 2D DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 850 MHZ; 800 MHZ; 700 REMARK 210 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, NMRFAM-SPARKY, PINE REMARK 210 -SPARKY, NMRPIPE, NMRDRAW, ARIA, REMARK 210 NMREST REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HA ARG A 171 H GLY A 229 1.25 REMARK 500 HG LEU A 127 HG LEU A 156 1.32 REMARK 500 HB VAL A 14 OG1 THR A 121 1.46 REMARK 500 O PRO A 102 H LYS A 106 1.48 REMARK 500 O ALA A 52 H ALA A 56 1.49 REMARK 500 O TYR A 179 H LEU A 183 1.51 REMARK 500 O VAL A 14 H VAL A 18 1.56 REMARK 500 O LEU A 74 H ILE A 138 1.58 REMARK 500 H GLY A 163 O LYS A 236 1.58 REMARK 500 O LYS A 180 H GLU A 184 1.58 REMARK 500 O LEU A 105 H ARG A 109 1.58 REMARK 500 O LEU A 55 H CYS A 59 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 8 -51.74 -169.46 REMARK 500 1 ARG A 10 -77.63 -41.60 REMARK 500 1 SER A 21 -162.07 55.93 REMARK 500 1 ALA A 52 -63.97 -25.68 REMARK 500 1 CYS A 120 90.02 169.98 REMARK 500 1 SER A 144 97.70 -55.05 REMARK 500 1 GLU A 145 40.93 174.12 REMARK 500 1 GLN A 147 -79.82 -90.03 REMARK 500 1 THR A 170 -162.60 170.26 REMARK 500 1 GLU A 215 177.25 137.34 REMARK 500 1 LEU A 218 54.55 40.00 REMARK 500 1 GLN A 237 98.17 40.37 REMARK 500 2 GLN A 5 73.03 60.12 REMARK 500 2 ALA A 8 -27.57 -178.64 REMARK 500 2 SER A 21 -164.30 66.69 REMARK 500 2 LYS A 49 54.58 74.63 REMARK 500 2 CYS A 120 74.38 -167.36 REMARK 500 2 LEU A 127 160.99 -44.29 REMARK 500 2 PRO A 128 22.08 -68.60 REMARK 500 2 SER A 144 102.39 -54.58 REMARK 500 2 GLU A 145 46.14 173.81 REMARK 500 2 GLN A 147 -79.81 -91.16 REMARK 500 2 PRO A 154 -16.34 -49.52 REMARK 500 2 THR A 170 -169.55 179.30 REMARK 500 2 ASN A 173 99.00 161.68 REMARK 500 2 TRP A 196 -176.97 -170.94 REMARK 500 2 LEU A 199 -90.84 -119.65 REMARK 500 2 ASN A 223 61.37 73.29 REMARK 500 2 GLN A 237 107.36 47.69 REMARK 500 3 SER A 21 -158.83 60.93 REMARK 500 3 ALA A 52 -56.83 -29.63 REMARK 500 3 CYS A 78 20.02 -71.42 REMARK 500 3 CYS A 120 85.67 -177.17 REMARK 500 3 LEU A 122 179.47 179.64 REMARK 500 3 SER A 144 99.96 -62.65 REMARK 500 3 GLU A 145 45.05 175.73 REMARK 500 3 GLN A 147 -78.87 -90.33 REMARK 500 3 THR A 170 -170.43 175.64 REMARK 500 3 CYS A 198 97.67 -64.75 REMARK 500 3 SER A 212 -150.35 176.94 REMARK 500 3 ILE A 230 144.62 -174.38 REMARK 500 3 GLN A 237 107.26 38.24 REMARK 500 4 SER A 21 -165.13 64.39 REMARK 500 4 CYS A 120 71.39 -161.75 REMARK 500 4 SER A 144 106.46 -54.28 REMARK 500 4 GLU A 145 49.53 165.63 REMARK 500 4 GLN A 147 -79.98 -89.99 REMARK 500 4 PRO A 149 109.12 -47.31 REMARK 500 4 CYS A 150 -24.29 -39.92 REMARK 500 4 THR A 170 -173.46 178.80 REMARK 500 REMARK 500 THIS ENTRY HAS 271 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 27417 RELATED DB: BMRB REMARK 900 WILLIAMS-BEUREN SYNDROME RELATED METHYLTRANSFERASE WBSCR27 IN REMARK 900 COMPLEX WITH SAH DBREF 7QCB A 5 240 UNP Q8BGM4 Q8BGM4_MOUSE 3 238 SEQADV 7QCB GLY A 1 UNP Q8BGM4 EXPRESSION TAG SEQADV 7QCB ALA A 2 UNP Q8BGM4 EXPRESSION TAG SEQADV 7QCB MET A 3 UNP Q8BGM4 EXPRESSION TAG SEQADV 7QCB ALA A 4 UNP Q8BGM4 EXPRESSION TAG SEQRES 1 A 240 GLY ALA MET ALA GLN GLU GLU ALA GLY ARG LEU PRO GLN SEQRES 2 A 240 VAL LEU ALA ARG VAL GLY THR SER HIS GLY ILE THR ASP SEQRES 3 A 240 LEU ALA CYS LYS LEU ARG PHE TYR ASP ASP TRP ALA PRO SEQRES 4 A 240 GLU TYR ASP GLN ASP VAL ALA ALA LEU LYS TYR ARG ALA SEQRES 5 A 240 PRO ARG LEU ALA VAL ASP CYS LEU SER ARG ALA PHE ARG SEQRES 6 A 240 GLY SER PRO HIS ASP ALA LEU ILE LEU ASP VAL ALA CYS SEQRES 7 A 240 GLY THR GLY LEU VAL ALA VAL GLU LEU GLN ALA ARG GLY SEQRES 8 A 240 PHE LEU GLN VAL GLN GLY VAL ASP GLY SER PRO GLU MET SEQRES 9 A 240 LEU LYS GLN ALA ARG ALA ARG GLY LEU TYR HIS HIS LEU SEQRES 10 A 240 SER LEU CYS THR LEU GLY GLN GLU PRO LEU PRO ASP PRO SEQRES 11 A 240 GLU GLY THR PHE ASP ALA VAL ILE ILE VAL GLY ALA LEU SEQRES 12 A 240 SER GLU GLY GLN VAL PRO CYS SER ALA ILE PRO GLU LEU SEQRES 13 A 240 LEU ARG VAL THR LYS PRO GLY GLY LEU VAL CYS LEU THR SEQRES 14 A 240 THR ARG THR ASN PRO SER ASN LEU PRO TYR LYS GLU THR SEQRES 15 A 240 LEU GLU ALA THR LEU ASP SER LEU GLU ARG ALA GLY VAL SEQRES 16 A 240 TRP GLU CYS LEU VAL THR GLN PRO VAL ASP HIS TRP GLU SEQRES 17 A 240 LEU ALA THR SER GLU GLN GLU THR GLY LEU GLY THR CYS SEQRES 18 A 240 ALA ASN ASP GLY PHE ILE SER GLY ILE ILE TYR LEU TYR SEQRES 19 A 240 ARG LYS GLN GLU THR VAL HET SAH A 300 46 HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE FORMUL 2 SAH C14 H20 N6 O5 S HELIX 1 AA1 ALA A 2 GLY A 9 1 8 HELIX 2 AA2 GLY A 9 SER A 21 1 13 HELIX 3 AA3 GLY A 23 LYS A 49 1 27 HELIX 4 AA4 ARG A 51 PHE A 64 1 14 HELIX 5 AA5 THR A 80 GLY A 91 1 12 HELIX 6 AA6 SER A 101 GLY A 112 1 12 HELIX 7 AA7 ALA A 152 VAL A 159 1 8 HELIX 8 AA8 PRO A 178 GLY A 194 1 17 HELIX 9 AA9 ASP A 205 THR A 211 1 7 HELIX 10 AB1 LEU A 218 ASN A 223 1 6 SHEET 1 AA1 7 HIS A 116 LEU A 119 0 SHEET 2 AA1 7 VAL A 95 ASP A 99 1 N GLY A 97 O HIS A 116 SHEET 3 AA1 7 ILE A 73 ASP A 75 1 N ILE A 73 O GLN A 96 SHEET 4 AA1 7 PHE A 134 ILE A 138 1 O ILE A 138 N LEU A 74 SHEET 5 AA1 7 THR A 160 THR A 170 1 O CYS A 167 N VAL A 137 SHEET 6 AA1 7 ILE A 230 LYS A 236 -1 O LYS A 236 N GLY A 163 SHEET 7 AA1 7 TRP A 196 GLN A 202 -1 N GLU A 197 O ARG A 235 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1